BioGeneration Ventures

BioGeneration Ventures is investing in the next generation of Life Sciences companies in the Netherlands.

Business Model:

Revenue: $3.8M

Employees: 11-50

Rankings

Detailed BioGeneration Ventures Information

Geographic Data

BioGeneration Ventures headquarters map

Address: Gooimeer 2-35

City: Naarden

State: drente

Zip: 1411 DC

Country: NL

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$486M

Metrics

4,723,351Website Global Rank

1,848Website Monthly Traffic

Twitter Followers

Description

BioGeneration Ventures is investing in the next generation of Life Sciences companies in the Netherlands. BioGeneration Ventures invests in Dutch start-up and early stage life sciences companies. The BioGeneration Ventures team is specialized in the evaluation and management of early stage companies. Their involvement goes beyond the financial investment. They work closely with scientists, academic institutions, entrepreneurs and industry experts to accelerate the development and to optimize the commercial potential of their portfolio company&s;s technologies. BioGeneration Ventures began operating in 2006 and the fund is backed by the Netherlands Genomics Initiative (NGI) and the Netherlands Organisation for Scientific Research (NWO) in combination with the holding company of Leiden University and ABN-AMRO Capital as lead private investors.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
12/2017 NorthSea Therapeutics Series A 29.4M
2/2022 Complement Therapeutics Seed Round 5.7M
12/2009 Medisse Venture Round -
2/2014 Synaffix BV Series A -
3/2018 Escalier Biosciences Series B 19M
6/2017 Scenic Biotech Series A 7.3M
1/2020 Tiga TX Venture Round -
7/2018 Azafaros Seed Round -
3/2013 AcertaPharma Series A 60M
1/2018 Mironid Venture Round -
9/2022 Phosphoenix Pre Seed Round -
1/2019 Genase Therapeutics Venture Round -
3/2009 FlexGen Private Equity Round -
1/2021 Complement Therapeutics Seed Round -
9/2009 arGEN-X Series A 13.6M
3/2022 Scenic Biotech Series A 0
4/2023 Complement Therapeutics Series A 0
1/2014 Staten Biotechnology Venture Round -
7/2020 Citryll Series B 0
1/2020 Fibrocor Therapeutics Venture Round -
1/2016 Mucosis Venture Round 6.2M
2/2010 arGEN-X Series A 4.5M
11/2012 Lanthio Pharma Series A 6.2M
4/2014 Mucosis Venture Round 0
9/2007 Mucosis Series A 0
1/2007 Noviogendix Holding Venture Round -
11/2022 FundaMental Pharma Seed Round 10.4M
1/2017 Cristal Therapeutics Venture Round 0
1/2019 New Amsterdam Pharma Venture Round -
2/2013 Dezima Pharma Venture Round 18.6M
1/2020 Dualyx Venture Round -
5/2023 VarmX Series B 0
11/2021 Dunad Therapeutics Series A 0
1/2020 NorthSea Therapeutics Series B 40M
12/2014 Cristal Therapeutics Venture Round 7.5M
8/2017 Mellon Medical Series B 7.1M
11/2022 CatalYm Series C 0
1/2022 River BioMedics Seed Round 0
11/2020 Catalym Series B 59.3M
2/2020 Azafaros Series A 27.5M
7/2020 VarmX Series B 36.3M
5/2019 Confo Therapeutics Series A 33.6M
5/2023 Dualyx Series A 0
12/2021 NorthSea Therapeutics Series C 0
7/2018 VarmX Series A 8.7M
1/2013 SurgVision Venture Round -
6/2017 VarmX Seed Round 1.1M
1/2008 Progentix Orthobiology Venture Round -
3/2022 Scenic Biotech Series A 0
2/2022 Complement Therapeutics Seed Round 0
1/2022 River BioMedics Seed Round 0
12/2021 NorthSea Therapeutics Series C 0
11/2021 Dunad Therapeutics Series A 0
1/2021 Complement Therapeutics Seed Round -
11/2020 Catalym Series B 0
7/2020 VarmX Series B 0
7/2020 Citryll Series B 0
2/2020 Azafaros Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research
CoBee's Logo
Copyright © CoBee 2022. All Rights Reserved.